Delivery Order SPE2DB22D2206-SPE2DB24FJE82

Award Date 7/15/24
Potential Completion Date 8/5/24
Potential Value $110K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FKH15, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $110,408.40, is for the delivery of 4,565,780,137 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 3, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and...
This federal contract award, with an ID of SPE2DB22D2007|SPE2DB24FJ1TB, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $43,856.92 firm fixed-price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The award is not associated with any set-aside designation and has an ultimate completion date of May 10, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $64,413.24 firm-fixed-price delivery order is to provide DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 16, 2024. This award is a task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB22D2007|SPE2DB24FJ5TV, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $44,163.36 firm fixed-price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract has a completion date of September 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,940.63, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. It is a firm fixed-price delivery order contract with an ultimate completion date of January 24, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEWM2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $33,900.74 firm-fixed-price delivery order is for the supply of 4,564,881,014 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The award is not associated with a set-aside designation and has a completion date of July 3, 2024. AmerisourceBergen, a major pharmaceutical distribution company,...
This federal contract award, valued at $16,561.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is October 15, 2024. The award does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This federal contract award, valued at $124,028.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22FP0U3) for the supply of DARZALEX FASPRO, a specialty medication, with an ultimate completion date of July 22, 2022. The contract is a firm fixed-price arrangement, and no set-aside designation was used. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $110,408.40 Firm Fixed Price delivery order is for the provision of DARZALEX FASPRO 1,800MG-30,000 15ML, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 firm-fixed-price delivery order is for the supply of 4,566,326,839 units of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJE82
    Delivery Order

This federal contract award, with ID SPE2DB22D2206|SPE2DB24FJE82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $110,408.40 firm-fixed-price delivery order is for the supply of 4565151397 - DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product.

The contract has an ultimate completion date of August 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of medical commodities to support the Department of Defense globally. The company also has a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 10/14/24, 10:09 AM